The Certification Study Guide (6th edition) emphasizes that device-associated infection rates must be calculated using time-at-risk denominators to accurately reflect patient exposure. For CLABSI surveillance, the most appropriate denominator is central line days, defined as the total number of days patients have one or more central lines in place during the surveillance period.

Using central line days accounts for both the presence and duration of exposure, which is critical for risk adjustment. The longer a central line remains in place, the greater the opportunity for microbial entry and bloodstream infection. This denominator allows for valid trend analysis over time and meaningful benchmarking with national surveillance systems that use standardized definitions and denominators.

The other options are incorrect because they fail to measure exposure accurately. Total ICU patients and total patients with central lines do not account for how long the device was present. Counting only patients who developed infections incorrectly places outcomes in the denominator, which invalidates rate calculations.

The study guide reinforces that numerators represent infection events, while denominators represent populations or time at risk. For CLABSI, the standard rate is expressed as infections per 1,000 central line days, a core concept frequently tested on the CIC exam.

Accurate denominator selection ensures valid surveillance, supports quality improvement efforts, and enables comparison with national benchmarks—making central line days the correct and most appropriate choice.